Sign in or register to see full information and data.

Studies / HVTN 108

Overview

Study information

Network:HVTN
Grant Affiliation:NA
Strategy:NA
Study Type:Phase I/IIa
Species:Human
Stage:Follow up complete
Study Start Date:NA
Study Made Public:NA

Title

A Phase 1/2a clinical trial to evaluate the safety and immunogenicity of HIV clade C DNA, and of MF59- or AS01B-adjuvanted clade C Env protein, in healthy, HIV-uninfected adult participants

Description

HVTN 108 is a Phase I/IIa clinical trial to evaluate the safety and immunogenicity of DNA-HIV-PT123 and bivalent subtype C gp120 (with MF59 or AS01B).

Products

Product info coming soon!

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.